发明名称 2,4,6-TRIAMINO-1,3,5-TRIAZINE DERIVATIVE
摘要 <p>This invention relates to an anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient. &lt;??&gt;It was proved that the BEC 1 potassium channel inhibitor has an action to improve learning disorder and is useful as a preventive or therapeutic agent for diseases, preferably dementia, in which the BEC 1 potassium channel is considered to be concerned. &lt;??&gt;Illustratively, it was confirmed by an in vivo test that the BEC 1 potassium channel inhibitor has an action to improve learning disorder. &lt;??&gt;Also, it was found that a compound having 2,4,6-triamino-1,3,5-triazine has a BEC 1 potassium channel inhibitory action.</p>
申请公布号 EP1479397(A1) 申请公布日期 2004.11.24
申请号 EP20030737464 申请日期 2003.02.03
申请人 ASTELLAS PHARMA INC. 发明人 KUBOTA, HIDEKI;SUZUKI, TAKESHI;MIURA, MASANORI;NAKAI, EIICHI;YAHIRO, KIYOSHI;MIYAKE, AKIRA;MOCHIZUKI, SHINOBU;NAKATO, KAZUHIRO
分类号 C07D405/12;A61K31/53;A61P25/28;A61P43/00;C07D251/70;C07D401/12;C07D403/12;C07D409/12;C07D413/12;C07D417/12;C07D453/02;C07D471/04;C07D491/04;(IPC1-7):A61K45/00 主分类号 C07D405/12
代理机构 代理人
主权项
地址